Computational Pathology Market Size, Share & Trends Analysis Report by Component (Software, Services) by Application, Technology (Natural Language Processing Models), End-use (Hospitals & Diagnostic Labs), Region, with Growth Forecasts, 2025-2030

The Computational Pathology Market was valued at USD 655.8 Million in 2024, and is projected to reach USD 1.04 Billion by 2030, rising at a CAGR of 8.24%. This growth can be attributed to the rising prevalence of chronic diseases, the increasing demand for advanced solutions for faster diagnosis, the rising integration of Machine Learning (ML) and artificial intelligence (AI) technologies and increasing investment in healthcare supported by market players focused on developing advanced solutions.

Integrating artificial intelligence (AI) and machine learning (ML) algorithms into digital pathology workflows is revolutionizing the field, enabling faster and more accurate analysis of pathology images. AI-powered tools can assist pathologists in detecting patterns, predicting disease progression, and giving clinically relevant insights crucial for disease detection. For instance, In September 2024, Paige introduced Paige Alba, a clinical-grade multimodal co-pilot aimed at transforming personalized medicine and precision oncology. Alba provides real-time, AI-driven insights from patient data, enhancing clinical decision-making at unprecedented speed and scale. This innovation represents a major leap toward Artificial General Intelligence (AGI) in healthcare, bringing the industry closer to a future where AI not only supports but collaborates with clinicians in diagnosing and treating complex diseases such as cancer.

Several companies operating in the market also focusing on developing innovative solutions to enhance the application and performance of computational pathology. For instance, in August 2023, Microsoft and Paige researchers developed Virchow2 and Virchow2G, second-generation foundation models for computational pathology. These large language models are trained on vast amounts of pathology data to understand the complex relationships between clinical information, pathology findings, and disease outcomes.

Virchow2 and Virchow2G can generate human-readable text, answer questions, and assist in tasks like report generation and case summarization. The models are designed to be fine-tuned for specific tasks, enabling their use in various computational pathology applications. This advancement represents a significant step forward in leveraging AI to enhance pathologists' decision-making and improve patient care in computational pathology. Similarly, transitioning from traditional microscopy to digital pathology further contributes to the market growth. This shift enhances accessibility and facilitates remote consultations and collaborative efforts among pathologists worldwide.

The COVID-19 pandemic has accelerated this trend as healthcare systems search for alternatives to execute operations while ensuring compliance with safety protocols. Furthermore, regulatory bodies significantly contribute to digital pathology's growth, leading to approvals for various digital imaging systems and software applications. As organizations invest in infrastructure to support digital workflows, the market is expected to witness significant growth driven by enhanced operational efficiencies and improved diagnostic capabilities.

Computational Pathology Market Report Highlights

Based on component, software segment dominated the market in 2024 owing to the various advantages offered by these solutions that help in enhancing clinical workflows.
Based on application, disease diagnosis dominated the application segment with a revenue share of 45.7% in 2024 owing to the rising demand for more effective and accurate diagnosis tools in hospitals and diagnostics centers globally.
Based on technology, machine learning dominated the market in 2024 owing to the rising development of computational pathology solutions with integrated ML technologies that offer better performance and outcomes in healthcare facilities.
Based on end use, hospitals and diagnostic labs segment held the largest market share of 51.09% in 2024, driven by the increasing demand for advanced diagnostic tools and efficient workflow solutions.
North America held the largest market share of 40.5% in 2024. This can be attributed to the regions developed healthcare infrastructure and increasing access to the computational pathology solutions coupled with the rising incidents of the chronic diseases such as cancer.
Major players are employing various strategies such as product launches, collaborations, acquisitions, and mergers to expand their service portfolios and enhance their geographical presence, leading to significant competition within the market. For instance, in February 2023, ClaraPath acquired Crosscope to integrate tissue processing robotics with AI-powered digital pathology, aiming to create the "lab of the future." This combination enhances workflow efficiency by automating tissue processing while leveraging AI technologies for advanced image analysis and diagnostics.

Why Should You Buy This Report?

Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
Competitive Landscape: Explore the market presence of key players.
Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

Market intelligence to enable effective decision-making
Market estimates and forecasts from 2018 to 2030
Growth opportunities and trend analyses
Segment and regional revenue forecasts for market assessment
Competition strategy and market share analysis
Product innovation listings for you to stay ahead of the curve

Chapter 1. Research Methodology and Scope

1.1. Market Segmentation & Scope
1.1.1. Regional scope
1.1.2. Component
1.1.3. Technology
1.1.4. Application
1.1.5. End Use
1.1.6. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Component
2.2.2. Technology
2.2.3. Application
2.2.4. End Use
2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Computational Pathology Market Variables, Trends & Scope

3.1. Market Dynamics
3.1.1. Market driver analysis
3.1.2. Market restraint analysis
3.1.3. Market Opportunity Analysis
3.2. Computational Pathology Market Analysis Tools
3.2.1. Industry Analysis - Porter’s
3.2.1.1. Supplier power
3.2.1.2. Buyer power
3.2.1.3. Substitution threat
3.2.1.4. Threat of new entrant
3.2.1.5. Competitive rivalry
3.2.2. PESTEL Analysis
3.2.2.1. Political landscape
3.2.2.2. Economic landscape
3.2.2.3. Social landscape
3.2.2.4. Technological landscape
3.2.2.5. Environmental landscape
3.2.2.6. Legal landscape
3.2.3. Emerging Technology Trends
3.2.4. COVID-19 Impact Analysis
3.2.5. Case Study Analysis

Chapter 4. Computational Pathology Market: Component Estimates & Trend Analysis

4.1. Component Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Computational Pathology Market by Component Outlook
4.4. Software
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Services
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Computational Pathology Market: Application Estimates & Trend Analysis

5.1. Application Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Computational Pathology Market by Application Outlook
5.4. Disease Diagnosis
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Drug Discovery & Development
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Academic Research
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Computational Pathology Market: Technology Estimates & Trend Analysis

6.1. Technology Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. Global Computational Pathology Market by Technology Outlook
6.4. Machine Learning (ML)
6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.2. Deep Learning
6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.3. Others
6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5. Natural Language Processing (NLP) Models
6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.6. Computer Vision
6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Computational Pathology Market: End Use Estimates & Trend Analysis

7.1. End Use Market Share, 2024 & 2030
7.2. Segment Dashboard
7.3. Global Computational Pathology Market by End Use Outlook
7.4. Hospitals and Diagnostic Labs
7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.5. Biotechnology and Pharmaceutical Companies
7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.6. Academic and Research Institutes
7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.7. Others
7.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Computational Pathology Market: Regional Estimates & Trend Analysis, by Component, by Application, by Technology, by End Use

8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. U.S.
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework
8.5.1.3. Competitive scenario
8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. Canada
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
8.6.1. UK
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework
8.6.1.3. Competitive scenario
8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Germany
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. France
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. Italy
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Spain
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Norway
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Sweden
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework
8.6.7.3. Competitive scenario
8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.6.8. Denmark
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework
8.6.8.3. Competitive scenario
8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Japan
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework
8.7.1.3. Competitive scenario
8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. China
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. India
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Competitive scenario
8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Australia
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework
8.7.4.3. Competitive scenario
8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.5. South Korea
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework
8.7.5.3. Competitive scenario
8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.7.6. Thailand
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework
8.7.6.3. Competitive scenario
8.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework
8.8.1.3. Competitive scenario
8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. Argentina
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. MEA
8.9.1. South Africa
8.9.1.1. Key country dynamics
8.9.1.2. Regulatory framework
8.9.1.3. Competitive scenario
8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.9.2. Saudi Arabia
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework
8.9.2.3. Competitive scenario
8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.9.3. UAE
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework
8.9.3.3. Competitive scenario
8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.9.4. Kuwait
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework
8.9.4.3. Competitive scenario
8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company/Competition Categorization
9.3. Key company market share/position analysis, 2024
9.4. Company Profiles
9.4.1. Leica Biosystems Nussloch GmbH (Danaher)
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Hamamatsu Photonics K.K.
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Koninklijke Philips N.V.
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Olympus Corporation
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. F. Hoffmann-La Roche Ltd.
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Mikroscan Technologies, Inc.
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Epredia (3DHISTECH Ltd.)
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Visiopharm a/S
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Proscia Inc.
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Tempus
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. Huron Technologies International Inc.
9.4.11.1. Company overview
9.4.11.2. Financial performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives
9.4.12. ContextVision AB
9.4.12.1. Company overview
9.4.12.2. Financial performance
9.4.12.3. Product benchmarking
9.4.12.4. Strategic initiatives
9.4.13. CellaVision
9.4.13.1. Company overview
9.4.13.2. Financial performance
9.4.13.3. Product benchmarking
9.4.13.4. Strategic initiatives
9.4.14. aetherAI
9.4.14.1. Company overview
9.4.14.2. Financial performance
9.4.14.3. Product benchmarking
9.4.14.4. Strategic initiatives
9.4.15. CellCarta
9.4.15.1. Company overview
9.4.15.2. Financial performance
9.4.15.3. Product benchmarking
9.4.15.4. Strategic initiatives
9.4.16. IBEX (IBEX MEDICAL ANALYTICS)
9.4.16.1. Company overview
9.4.16.2. Financial performance
9.4.16.3. Product benchmarking
9.4.16.4. Strategic initiatives
9.4.17. Nucleai, Inc.
9.4.17.1. Company overview
9.4.17.2. Financial performance
9.4.17.3. Product benchmarking
9.4.17.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 North America Computational Pathology Market, By Region, 2018-2030 (USD Million)
Table 3 North America Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 4 North America Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 5 North America Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 6 North America Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 7 U.S. Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 8 U.S. Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 9 U.S. Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 10 U.S. Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 11 Canada Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 12 Canada Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 13 Canada Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 14 Canada Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 15 Mexico Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 16 Mexico Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 17 Mexico Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 18 Mexico Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 19 Europe Computational Pathology Market, By Region, 2018-2030 (USD Million)
Table 20 Europe Computational Pathology Market, By Component, 2018-2030 (USD Million)
Table 21 Europe Computational Pathology Market, By Technology, 2018-2030 (USD Million)
Table 22 Europe Computational Pathology Market, By Application, 2018-2030 (USD Million)
Table 23 Europe Computational Pathology Market, By End use, 2018-2030 (USD Million)
Table 24 Germany Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 25 Germany Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 26 Germany Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 27 Germany Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 28 UK Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 29 UK Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 30 UK Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 31 UK Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 32 France Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 33 France Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 34 France Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 35 France Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 36 Italy Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 37 Italy Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 38 Italy Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 39 Italy Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 40 Spain Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 41 Spain Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 42 Spain Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 43 Spain Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 44 Denmark Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 45 Denmark Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 46 Denmark Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 47 Denmark Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 48 Sweden Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 49 Sweden Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 50 Sweden Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 51 Sweden Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 52 Norway Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 53 Norway Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 54 Norway Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 55 Norway Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 56 Asia Pacific Computational Pathology Market, by region, 2018-2030 (USD Million)
Table 57 Asia Pacific Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 58 Asia Pacific Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 59 Asia Pacific Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 60 Asia Pacific Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 61 China Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 62 China Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 63 China Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 64 China Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 65 Japan Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 66 Japan Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 67 Japan Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 68 Japan Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 69 India Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 70 India Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 71 India Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 72 India Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 73 South Korea Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 74 South Korea Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 75 South Korea Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 76 South Korea Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 77 Australia Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 78 Australia Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 79 Australia Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 80 Australia Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 81 Thailand Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 82 Thailand Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 83 Thailand Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 84 Thailand Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 85 Latin America Computational Pathology Market, by region, 2018-2030 (USD Million)
Table 86 Latin America Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 87 Latin America Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 88 Latin America Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 89 Latin America Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 90 Brazil Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 91 Brazil Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 92 Brazil Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 93 Brazil Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 94 Argentina Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 95 Argentina Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 96 Argentina Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 97 Argentina Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 98 MEA Computational Pathology Market, by region, 2018-2030 (USD Million)
Table 99 MEA Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 100 MEA Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 101 MEA Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 102 MEA Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 103 South Africa Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 104 South Africa Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 105 South Africa Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 106 South Africa Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 107 Saudi Arabia Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 108 Saudi Arabia Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 109 Saudi Arabia Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 110 Saudi Arabia Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 111 UAE Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 112 UAE Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 113 UAE Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 114 UAE Computational Pathology Market By End use, 2018-2030 (USD Million)
Table 115 Kuwait Computational Pathology Market, 2018-2030 (USD Million)
Table 116 Kuwait Computational Pathology Market By Component, 2018-2030 (USD Million)
Table 117 Kuwait Computational Pathology Market By Technology, 2018-2030 (USD Million)
Table 118 Kuwait Computational Pathology Market By Application, 2018-2030 (USD Million)
Table 119 Kuwait Computational Pathology Market By End use, 2018-2030 (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Computational Pathology Market outlook
Figure 9 Computational Pathology competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Computational Pathology Market driver impact
Figure 15 Computational Pathology Market restraint impact
Figure 16 Computational Pathology Market strategic initiatives analysis
Figure 17 Computational Pathology Market: Component movement analysis
Figure 18 Computational Pathology Market: Component outlook and key takeaways
Figure 19 Software market estimates and forecast, 2018-2030
Figure 20 Services market estimates and forecast, 2018-2030
Figure 21 Computational Pathology Market: Application movement analysis
Figure 22 Computational Pathology Market: Application outlook and key takeaways
Figure 23 Disease diagnosis market estimates and forecast, 2018-2030
Figure 24 Drug discovery & development market estimates and forecast, 2018-2030
Figure 25 Academic research market estimates and forecast, 2018-2030
Figure 26 Computational Pathology Market: Technology movement analysis
Figure 27 Computational Pathology Market: Technology outlook and key takeaways
Figure 28 Machine Learning (ML) market estimates and forecast, 2018-2030
Figure 29 Deep Learning market estimates and forecast, 2018-2030
Figure 30 Others market estimates and forecast, 2018-2030
Figure 31 Natural Language Processing (NLP) models market estimates and forecast, 2018-2030
Figure 32 Computer vision market estimates and forecast, 2018-2030
Figure 33 Others market estimates and forecast, 2018-2030
Figure 34 Computational Pathology Market: End use movement analysis
Figure 35 Computational Pathology Market: End use outlook and key takeaways
Figure 36 Hospitals and Diagnostic Labs market estimates and forecast, 2018-2030
Figure 37 Biotechnology and Pharmaceutical Companies market estimates and forecast, 2018-2030
Figure 38 Academic and Research Institutes market estimates and forecast, 2018-2030
Figure 39 Other market estimates and forecast, 2018-2030
Figure 40 Global Computational Pathology Market: Regional movement analysis
Figure 41 Global Computational Pathology Market: Regional outlook and key takeaways
Figure 42 Global Computational Pathology Market share and leading players
Figure 43 North America market share and leading players
Figure 44 Europe market share and leading players
Figure 45 Asia Pacific market share and leading players
Figure 46 Latin America market share and leading players
Figure 47 Middle East & Africa market share and leading players
Figure 48 North America market estimates and forecasts, 2018-2030
Figure 49 U.S. market estimates and forecasts, 2018-2030
Figure 50 Canada market estimates and forecasts, 2018-2030
Figure 51 Mexico market estimates and forecasts, 2018-2030
Figure 52 Europe market estimates and forecasts, 2018-2030
Figure 53 UK market estimates and forecasts, 2018-2030
Figure 54 Germany market estimates and forecasts, 2018-2030
Figure 55 France market estimates and forecasts, 2018-2030
Figure 56 Italy market estimates and forecasts, 2018-2030
Figure 57 Spain market estimates and forecasts, 2018-2030
Figure 58 Denmark market estimates and forecasts, 2018-2030
Figure 59 Sweden market estimates and forecasts, 2018-2030
Figure 60 Norway market estimates and forecasts, 2018-2030
Figure 61 Asia Pacific market estimates and forecasts, 2018-2030
Figure 62 China market estimates and forecasts, 2018-2030
Figure 63 Japan market estimates and forecasts, 2018-2030
Figure 64 India market estimates and forecasts, 2018-2030
Figure 65 Thailand market estimates and forecasts, 2018-2030
Figure 66 South Korea market estimates and forecasts, 2018-2030
Figure 67 Australia market estimates and forecasts, 2018-2030
Figure 68 Latin America market estimates and forecasts, 2018-2030
Figure 69 Brazil market estimates and forecasts, 2018-2030
Figure 70 Argentina market estimates and forecasts, 2018-2030
Figure 71 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 72 South Africa market estimates and forecasts, 2018-2030
Figure 73 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 74 UAE market estimates and forecasts, 2018-2030
Figure 75 Kuwait market estimates and forecasts, 2018-2030
Figure 76 Market share of key market players- Computational Pathology Market
Figure 77 Key Company Categorization
Figure 78 Company Market Share/Position Analysis, 2024
Figure 79 Strategic Framework

Companies Mentioned

The companies profiled in this Computational Pathology market report include:

Leica Biosystems Nussloch GmbH (Danaher)
Hamamatsu Photonics, Inc.
Koninklijke Philips N.V.
Olympus Corporation
F. Hoffmann-La Roche Ltd.
Mikroscan Technologies, Inc.
Epredia (3DHISTECH Ltd.)
Visiopharm A/S
Proscia Inc.
Tempus
Huron Technologies International Inc
ContextVision AB
CellaVision
aetherAI
CellCarta
IBEX (IBEX MEDICAL ANALYTICS)
Nucleai, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	100
Published	April 2025
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 655.8 Million
Forecasted Market Value ( USD ) by 2030	$ 1040 Million
Compound Annual Growth Rate	8.2%
Regions Covered	Global
No. of Companies Mentioned	18

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5499EUR$5,950USD£4,636GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6423EUR$6,950USD£5,415GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8272EUR$8,950USD£6,973GBP

Computational Pathology Market Report Highlights

Why Should You Buy This Report?

This report addresses:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Reports

LAMEA Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Country and Growth Forecast, 2025 - 2032

Europe Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Country and Growth Forecast, 2025 - 2032

Asia Pacific Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Country and Growth Forecast, 2025 - 2032

North America Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Country and Growth Forecast, 2025 - 2032

Digital Pathology Image Analysis Platform Market - Global Forecast to 2030